MacroGenics, Inc. (MGNX)Healthcare | Biotechnology | Rockville, United States | NasdaqGS
3.46 USD
+0.05
(1.466%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 3.46 Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 1:33 p.m. EDT
MGNX is a volatile biotech stock with a weak financial position, characterized by negative earnings, high debt-to-equity ratio, and a lack of consistent dividends. The recent price history shows a range-bound movement with no clear trend. While there are some signs of potential short-term momentum, the overall fundamentals and risk profile make it a speculative play. Long-term investors should be cautious, and short-term traders may look for opportunities in the dips or consider options strategies to manage risk. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.257318 |
| AutoARIMA | 0.311888 |
| AutoETS | 0.313135 |
| MSTL | 0.316482 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 26.00 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.058 |
| Excess Kurtosis | -1.74 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 66.129 |
| Revenue per Share | 2.367 |
| Market Cap | 219,917,840 |
| Forward P/E | -2.59 |
| Beta | 1.10 |
| Profit Margins | -49.91% |
| Website | https://www.macrogenics.com |
As of April 11, 2026, 1:33 p.m. EDT: Options speculators are showing mixed signals. The calls and puts data indicate that there is a significant amount of open interest and volume around strikes below the current price, particularly at the 2.0 strike, suggesting potential bearish sentiment. However, there is also some positioning around strikes above the current price, which could indicate bullish speculation. The overall volatility and the positioning suggest a cautious approach with limited directional clarity.
| Attribute | Value |
|---|---|
| 52 Week Change | 1.4532373 |
| Address1 | 9,704 Medical Center Drive |
| All Time High | 41.0 |
| All Time Low | 0.99 |
| Ask | 4.41 |
| Ask Size | 2 |
| Average Analyst Rating | 2.3 - Buy |
| Average Daily Volume10 Day | 989,660 |
| Average Daily Volume3 Month | 1,100,716 |
| Average Volume | 1,100,716 |
| Average Volume10Days | 989,660 |
| Beta | 1.096 |
| Bid | 2.53 |
| Bid Size | 2 |
| Book Value | 0.878 |
| City | Rockville |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.46 |
| Current Ratio | 5.101 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 3.545 |
| Day Low | 3.425 |
| Debt To Equity | 66.129 |
| Display Name | MacroGenics |
| Earnings Call Timestamp End | 1,742,502,600 |
| Earnings Call Timestamp Start | 1,742,502,600 |
| Earnings Timestamp | 1,773,086,400 |
| Earnings Timestamp End | 1,778,184,000 |
| Earnings Timestamp Start | 1,778,184,000 |
| Ebitda | -65,669,000 |
| Ebitda Margins | -0.43925998 |
| Enterprise To Ebitda | -1.016 |
| Enterprise To Revenue | 0.447 |
| Enterprise Value | 66,752,196 |
| Eps Current Year | -1.725 |
| Eps Forward | -1.335 |
| Eps Trailing Twelve Months | -1.19 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 301 251 5321 |
| Fifty Day Average | 2.5602 |
| Fifty Day Average Change | 0.89980006 |
| Fifty Day Average Change Percent | 0.35145694 |
| Fifty Two Week Change Percent | 145.32373 |
| Fifty Two Week High | 3.88 |
| Fifty Two Week High Change | -0.42000008 |
| Fifty Two Week High Change Percent | -0.10824744 |
| Fifty Two Week Low | 1.185 |
| Fifty Two Week Low Change | 2.275 |
| Fifty Two Week Low Change Percent | 1.9198314 |
| Fifty Two Week Range | 1.185 - 3.88 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,381,411,800,000 |
| Float Shares | 55,592,291 |
| Forward Eps | -1.335 |
| Forward P E | -2.5917602 |
| Free Cashflow | -58,232,124 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 293 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | -0.22529 |
| Gross Profits | -33,681,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.03373 |
| Held Percent Institutions | 0.64571 |
| Implied Shares Outstanding | 63,560,068 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule that targets an undisclosed antigen expressed across several solid tumors, which is in preclinical trials. It is also developing T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland. |
| Long Name | MacroGenics, Inc. |
| Market | us_market |
| Market Cap | 219,917,840 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_600911 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -74,620,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 219,282,234 |
| Number Of Analyst Opinions | 5 |
| Open | 3.48 |
| Operating Cashflow | -81,040,000 |
| Operating Margins | -0.29342 |
| Payout Ratio | 0.0 |
| Phone | 301 251 5172 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 3.46 |
| Post Market Time | 1,776,456,605 |
| Previous Close | 3.41 |
| Price Eps Current Year | -2.0057971 |
| Price Hint | 4 |
| Price To Book | 3.9407744 |
| Price To Sales Trailing12 Months | 1.4710224 |
| Profit Margins | -0.49912998 |
| Quick Ratio | 4.715 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.28571 |
| Region | US |
| Regular Market Change | 0.05 |
| Regular Market Change Percent | 1.46627 |
| Regular Market Day High | 3.545 |
| Regular Market Day Low | 3.425 |
| Regular Market Day Range | 3.425 - 3.545 |
| Regular Market Open | 3.48 |
| Regular Market Previous Close | 3.41 |
| Regular Market Price | 3.46 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 533,216 |
| Return On Assets | -0.17559999 |
| Return On Equity | -0.86945 |
| Revenue Growth | 1.13 |
| Revenue Per Share | 2.367 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 63,560,068 |
| Shares Percent Shares Out | 0.059499998 |
| Shares Short | 3,778,755 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 4,086,628 |
| Short Name | MacroGenics, Inc. |
| Short Percent Of Float | 0.0616 |
| Short Ratio | 2.36 |
| Source Interval | 15 |
| State | MD |
| Symbol | MGNX |
| Target High Price | 9.0 |
| Target Low Price | 2.0 |
| Target Mean Price | 4.8 |
| Target Median Price | 4.0 |
| Total Cash | 189,912,992 |
| Total Cash Per Share | 2.988 |
| Total Debt | 36,762,000 |
| Total Revenue | 149,500,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.19 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.855975 |
| Two Hundred Day Average Change | 1.604025 |
| Two Hundred Day Average Change Percent | 0.8642492 |
| Type Disp | Equity |
| Volume | 533,216 |
| Website | https://www.macrogenics.com |
| Zip | 20,850 |